Terravia Holdings (NASDAQ: TVIA) is one of 52 publicly-traded companies in the “Specialty Chemicals” industry, but how does it weigh in compared to its rivals? We will compare Terravia Holdings to similar businesses based on the strength of its analyst recommendations, valuation, risk, earnings, institutional ownership, dividends and profitability.

Institutional and Insider Ownership

43.4% of Terravia Holdings shares are owned by institutional investors. Comparatively, 69.7% of shares of all “Specialty Chemicals” companies are owned by institutional investors. 10.1% of Terravia Holdings shares are owned by insiders. Comparatively, 7.1% of shares of all “Specialty Chemicals” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent ratings for Terravia Holdings and its rivals, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Terravia Holdings 0 1 0 0 2.00
Terravia Holdings Competitors 164 1022 1275 24 2.47

Terravia Holdings presently has a consensus price target of $1.50, suggesting a potential upside of 3,659.40%. As a group, “Specialty Chemicals” companies have a potential downside of 3.08%. Given Terravia Holdings’ higher probable upside, analysts clearly believe Terravia Holdings is more favorable than its rivals.

Valuation & Earnings

This table compares Terravia Holdings and its rivals top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
Terravia Holdings N/A N/A -0.04
Terravia Holdings Competitors $1.96 billion $302.17 million 12.48

Terravia Holdings’ rivals have higher revenue and earnings than Terravia Holdings. Terravia Holdings is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.


This table compares Terravia Holdings and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Terravia Holdings -413.48% N/A -61.89%
Terravia Holdings Competitors -2.55% 9.11% 3.87%

Risk & Volatility

Terravia Holdings has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500. Comparatively, Terravia Holdings’ rivals have a beta of 1.59, meaning that their average stock price is 59% more volatile than the S&P 500.


Terravia Holdings rivals beat Terravia Holdings on 9 of the 11 factors compared.

Terravia Holdings Company Profile

Solazyme, Inc. creates renewable oils and bioproducts. The Company’s technology uses microalgae in an industrial fermentation process to transform a range of plant-based sugars into triglyceride oils and other bioproducts. The Company offers Algenist, a skin and personal care product available at Sephora S.A. and its affiliates, QVC, Inc., SpaceNK Limited, select Nordstrom stores and ULTA Beauty. It offers intermediates/ingredients, such as Tailored oils, powdered oils, and other closely related products targeted at customers in the industrial products, food products and personal care products markets. The Company’s commercial focus is to sell oils, encapsulated oils and whole algal powdered products to companies that use them as intermediates and ingredients.

Receive News & Ratings for Terravia Holdings Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Terravia Holdings and related companies with MarketBeat.com's FREE daily email newsletter.